Sinopharm Group Records Drop in Q1 2026 Profit
Sinopharm Group (HKG:1099) booked 1.41 billion yuan in attributable profit for the first quarter of 2026, falling from 1.46 billion yuan in the year-ago period, according to a Hong Kong bourse filing Monday.Earnings per share were 0.45 yuan, compared with 0.47 yuan in the prior year.Total operating revenue fell to 140.77 billion yuan from 141.66 billion yuan, figures showed.